Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 3, 2016
Click on the links below to view results for 2016 First Fiscal Quarter: View document online » PDF File of BD 2016 First Fiscal Quarter Results » About BD BD is one of the largest global medical...
-
Jan 25, 2016
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 66 cents per common share, payable on March 31, 2016 to holders of record on March 10,...
-
Jan 21, 2016BD leverages Singularity University’s network of solution-shaping experts, faculty, development partners and a highly-engaged global community
MOUNTAIN VIEW, CA and FRANKLIN LAKES, NJ January 21, 2016 – Singularity University (SU), a benefit corporation focused on empowering leaders to leverage exponentially growing technologies to...
-
Jan 15, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 26,...
-
Jan 8, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Fresenius Kabi USA has acquired the BD Rx business, which includes a...
-
Jan 8, 2016
FRANKLIN LAKES, N.J. and LAKE ZURICH, Ill.,January 8, 2016 – Becton, Dickinson and Company (BD) (NYSE: BDX) and Fresenius Kabi USA announced today that Fresenius Kabi has acquired the BD Rx...
-
Jan 7, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2016 earnings conference call on Wednesday, February 3, 2016, at 8:00...
-
Jan 4, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 34th Annual J. P. Morgan Healthcare Conference on...
-
Dec 12, 2015State-of-the-Art Research System Optimized for Use with BD Horizon Brilliant(TM) Dyes Is Now Available Worldwide
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSCelesta(TM) flow cytometer during the 2015 American Society...
-
Dec 10, 2015
FRANKLIN LAKES, N.J., Dec. 10, 2015 /PRNewswire/ – CareFusion, a BD company (NYSE:BDX), today announced the U.S. Food and Drug Administration (FDA) has cleared two 510(k)s for its spine...